MRNA Latest Headlines

FDA expands COVID-19 shot safety probe to include adults - report

at seekingalpha.com (Tue, 9-Dec 5:34 PM)

Moderna’s Growth Prospects: Balancing Revenue Potential and Legal Challenges

at www.tipranks.com (Tue, 9-Dec 7:15 AM)

Notable healthcare headlines for the week: UnitedHealth, Eli Lilly, and Bristol Myers in focus

at seekingalpha.com (Sun, 7-Dec 9:05 AM)

Moderna Targets 10% Revenue Growth by 2026 with Expanded Vaccine Pipeline and Streamlined Operations

Market Chameleon (Thu, 20-Nov 7:38 AM)

Moderna Set to Highlight mRNA Innovation at Piper Sandler Healthcare Conference—All Eyes on December 2 Event

Market Chameleon (Tue, 18-Nov 8:01 AM)

Moderna Lowers Costs and Narrows Revenue Outlook While Advancing Late-Stage Vaccine Pipeline

Market Chameleon (Thu, 6-Nov 8:04 AM)

Moderna Launches First Patient Study of Multiplexed mRNA T-Cell Engager for Multiple Myeloma

Market Chameleon (Mon, 3-Nov 7:14 AM)

Moderna Sets Date for Analyst Day: Upcoming Event Puts Focus on Strategic Vision and mRNA Innovations

Market Chameleon (Thu, 23-Oct 7:11 AM)

Moderna’s Flu Vaccine Shows 26.6% Higher Efficacy Over Standard: What New Data Reveals at IDWeek 2025

Market Chameleon (Mon, 20-Oct 7:09 AM)

MRNA-4359 Shows Promising 67% Response Rate in PD-L1+ Melanoma: Moderna Highlights Data at ESMO 2025

Market Chameleon (Mon, 13-Oct 7:12 AM)

Moderna Launches UK Facility With Capacity for 100 Million Doses, Pushing Forward on mRNA Innovation

Market Chameleon (Thu, 25-Sep 9:17 AM)

Moderna’s First Canadian-Made mRNA Vaccines Delivered—A Pivotal Moment for Domestic Production and Public Health

Market Chameleon (Mon, 22-Sep 7:41 AM)